Cargando…
Extended storage of SARS-CoV-2 nasopharyngeal swabs does not negatively impact results of molecular-based testing across three clinical platforms
With the global outbreak of COVID-19, the demand for testing rapidly increased and quickly exceeded the testing capacities of many laboratories. Clinical tests which receive CE (Conformité Européenne) and Food and Drug Administration (FDA) authorisations cannot always be tested thoroughly in a real-...
Autores principales: | Skalina, Karin A, Goldstein, D Y, Sulail, Jaffar, Hahm, Eunkyu, Narlieva, Momka, Szymczak, Wendy, Fox, Amy S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685649/ https://www.ncbi.nlm.nih.gov/pubmed/33144357 http://dx.doi.org/10.1136/jclinpath-2020-206738 |
Ejemplares similares
-
Utility of Stool PCR for the Diagnosis of COVID-19: Comparison of Two Commercial Platforms
por: Szymczak, Wendy A., et al.
Publicado: (2020) -
Variability in instructions for performance of nasopharyngeal swabs across Canada in the era of COVID-19 – what type of swab is actually being performed?
por: Hiebert, Nole M., et al.
Publicado: (2021) -
The sampling efficiencies of commercial nasopharyngeal swabs
por: Wang, Ying, et al.
Publicado: (2022) -
Adverse effects of nasopharyngeal swabs: Three-dimensional printed versus commercial swabs
por: Gupta, Kalpana, et al.
Publicado: (2020) -
A 3D-printed nasopharyngeal swab for COVID-19 diagnostic testing
por: Ford, Jonathan, et al.
Publicado: (2020)